Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-25-258574

Chief Financial Officer sold 21,664 shares at $7.29 ($157,931)

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-28 Sale : show line 1 in the form −21,664 $7.29 $157,931 313,631 D
Open-market sales · 21,664 sh · avg $7.29 · $157,931
Loading xslF345X05/ownership.xml…